eFFECTOR Therapeutics Inc. Gains 44.9%

Wed, Jan 04, 2023 at 07:00 PM
eFFECTOR Therapeutics Inc. Gains 44.9%

eFFECTOR Therapeutics Inc. (EFTR:NASDAQ) rocketted at $0.67, a gain of 44.9%. On Wed, Jan 04, 2023, EFTR:NASDAQ touched a New 2-Week High of $0.67. From Wed, Dec 21, 2022, the stock recorded 62.50% Up Days and 44.44% Green Days

The stock spiked on Tue, Aug 09, 2022 at $1.99 with a volume of 58M+.

About eFFECTOR Therapeutics Inc. (EFTR:NASDAQ)

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.